Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
201000009910diseases by infectious agentDiseases0.000claims2
229920000023polynucleotidePolymers0.000claims2
239000002157polynucleotideSubstances0.000claims2
229920001184polypeptidePolymers0.000claims2
230000002265preventionEffects0.000claims2
241001465754MetazoaSpecies0.000claims1
Claims (2)
請求項１に記載のポリペプチド若しくはその断片、請求項２に記載のポリヌクレオチド、又は請求項３に記載のベクターを、マダニ駆除の必要な対象に、有効量で投与することを含む、動物（ヒトを除く）におけるマダニ駆除方法。
An animal comprising administering the polypeptide according to claim 1 or a fragment thereof, the polynucleotide according to claim 2 or the vector according to claim 3 to a subject in need of tick control in an effective amount. Tick control method in (except human) .
請求項１に記載のポリペプチド若しくはその断片、請求項２に記載のポリヌクレオチド、又は請求項３に記載のベクターを、マダニ媒介性感染症の治療又は予防の必要な対象に、有効量で投与することを含む、動物（ヒトを除く）におけるマダニ媒介性感染症の治療又は予防方法。
An effective amount of the polypeptide according to claim 1 or a fragment thereof, the polynucleotide according to claim 2, or the vector according to claim 3 to a subject in need of treatment or prevention of a tick-borne infection. A method for the treatment or prevention of tick-borne infections in animals (excluding humans) .